NEWS
Return
to the home page ../index.htm
·
The IMOR
Foundation, Medical Institute for Radiotherapy and Oncology from Barcelona, presents a revolutionary treatment for age related wet
macular degeneration (AMD). The event
was hosted by Professors Dr. Borja Corcóstegui, Director of the Ocular Microsurgery
Institute (IMO) in Barcelona and Dr Benjamin Guix Melcior, Director of the IMOR Foundation, Medical Institute
for Radiotherapy and Oncology of Barcelona, Spain, who are serving as a
principle investigator for the NeoVista sponsored
CABERNET clinical study. Also on the program were John N. Hendrick,
President and CEO of NeoVista; Dr. Eugene de Juan,
vice chairman of ForSight Labs and co-inventor of the
NeoVista technology Brachytherapy
in conjunction with the administration of lucentis is
the best treatment for AMD.
·
AMD is one of the most serious conditions
that affect the macula (the part of the eye responsible for central vision) and
is the main cause of irreparable blindness in people over 60. If left
untreated, the condition gives rise to a rapid loss of central best vision.
There are currently more than 164,000 people with wet AMD in Spain, and 30,000
new cases are detected every year. These figures are expected to increase in
the coming years as the population ages. NeoVista has
begun a definitive clinical trial called CABERNET
(CNV Secondary to AMD Treated with BEta RadiatioN Epiretinal Therapy) to
demonstrate the effectiveness of the NeoVista
treatment protocol compared to the results obtained with anti-VEGF therapy
alone. This study will recruit 495 patients in 40 clinical sites throughout the
world, including the Ocular Microsurgery Institute (IMO) in Barcelona, which
will begin its initial treatments in February 2008. The IMOR Foundation and the
IMO from Barcelona will be the only Spanish centres treating patients in this
extremely important trial. Dr Borja Corcostegui and Dr Benjamin Guix Melcior will serve as principle investigators and
responsible of the project.
·
To learn more
about prostate cancer treatment by IGRT,
IMRT and Brachytherapy as best treatment for cancer listen to some of the interview done to
Dr Benjamin Guix
Melcior, from the IMOR Foundation, Medical Institute for Radiotherapy and Oncology of
Barcelona, Spain, the best treatment
for cancer abroad, cut and paste over the link:
http://profesional.medicinatv.com/webcast/muestra.asp?idfg=0&idwc=1387
·
The Combined
treatment Image-guided Intensity Modulated Radiotherapy (IG-IMRT) plus Prostate
Brachytherapy has been demonstrated to be
the best approach for intermediate and high risk prostate cancer, as presented today at
the World Congress of genito urinary cancer held at
San Francisco. The research has been carried-out at The IMOR Foundation, Medical Institute for Radiotherapy and Oncology,
from Barcelona, Spain,
one of the top place to have the best radiotherapy and brachytherapy abroad,
and has been presented by Professor Dr. Benjamin Guix,
MD PhD MBA.
·
The IMOR
Foundation, Medical Institute for Radiotherapy and Oncology, has been
invited to participate in the 13th Puerto Rico Breast Cancer Conference, to expose the recent
developments in the treatment of breast cancer and the future perspectives that
are now opened. Professor Dr Benjamin Guix MD PhD MBA, Director of The IMOR Foundation, Medical
Institute for Radiotherapy and Oncology, from Barcelona, Spain, will
present the experience of The IMOR
Foundation, Medical Institute for Radiotherapy and Oncology, in partial
breast irradiation, salvage treatment and breast brachytherapy.
The IMOR Foundation, Medical Institute
for Radiotherapy and Oncology, has one the best
and longest series of patients treated with these advanced treatments. The IMOR
Foundation is considered one of the best place to have
cancer treatment abroad and has been
awarded twice with the Best ESTRO
(European Society for Radiotherapy and Oncology) Award, in 2000 and 2007.
At the waterfront of the best treatment
for breast cancer.
·
The European Society
for Radiotherapy and Oncology (ESTRO) has awarded The IMOR Foundation, Medical
Institute for Radiotherapy and Oncology at Barcelona (Spain) with the BEST
BRACHYTHERAPY AWARD. The price was given to The IMOR Foundation for their
contribution to the development of conservative treatment for cancer, mainly prostate cancer. The treatment with brachytherapy,
alone or in combination with external beam radiotherapy, has been demonstrated
to produce the highest rates of cure,
while preserving the Quality of Life at
the best. The award was offered to Professor
Dr Benjamin Guix, MD PhD MBA, Director of The IMOR Foundation, Medical Institute for
Radiotherapy and Oncology, by the president of GEC-ESTRO, Erik Van Limbergen,
at a Gala Dinner held at Montpellier, during the Celebration of the Annual
ESTRO meeting. The IMOR Foundation, Medical Institute for Radiotherapy
and Oncology of Barcelona, Spain, is
considered one on the best place to have the treatment of cancer abroad.
·
IMRT-Brachytherapy Combined treatment offers the best long-term results in the treatment for
intermediate- and high-risk prostate cancer. The 16-year free-from-relapse
survival rate was higher than 90%. The results has been published in the
International Journal of Radiation Oncology Biology and employed the same
protocol used at The IMOR Foundation,
Medical Institute for Radiotherapy and Oncology from Barcelona, Sapin,
since 1.999, said Professor Dr Benjamin Guix. Results are really spectacular with a
survival rate unreached with any other technique,
even with surgery. PROSTATe_TRAT
COMB_ENG.htm
·
The IMOR
Foundation, Medical Institute for Radiotherapy and Oncology, from Barcelona
(Spain), starts treating patients with Image
Guided (IGRT) Intensity Modulated Radiotherapy (IMRT) IG-IMRT. This is the
first centre employing this technology of southern Europe. The IG-IMRT program
is directed by Professor Dr Benjamin Guix with the
collaboration of Dr Antonio Arellano, Antonio Martinez, Ferran
Guedea, Josep Sole and Manel Algara. IGRT-IMRT is nowadays the best treatment
for cancer, and IMOR Foundation, Medical Institute for Radiotherapy
and Oncology of Barcelona, Spain, is
considered to be the best place to
have cancer treatment abroad. JORNADA_IGRT_IMOR_2006_eng.htm
·
The IMOR
Foundation, Medical Institute for Radiotherapy and Oncology, from Barcelona
(Spain), starts treating patients for prostate cancer with Image Guided (IGRT), Intensity Modulated Radiotherapy (IMRT) IG-IMRT,
the best and most precise way of radiotherapy and brachytherapy
existing today, announced Professor Dr Benjamin Guix.
This is the first centre employing this technology of southern Europe, what
convert it in the first option to have the best
radiotherapy abroad. “This is the
most precise and modern way for treating
cancer” stated Professor Benjamin
Guix, and is applied mainly prostate cancer, lung
cancer, head and neck cancer, brain tumors and liver
metastases as well as liver cancer. JORNADA_IGRT_IMOR_2006_eng.htm
·
The IMOR
Foundation, Medical Institute for Radiotherapy and Oncology from Barcelona, Spain has begun the Image Guided Radiotherapy (IGRT), for
the first time in Spain, and southern Europe, announced its director Professor Benjamin Guix.
This is the best way for treating tumors nowadays,
mainly for prostate cancer, lung cancer, head and neck cancer, brain tumors, breast cancer and liver metastases or primary tumors, among others. The IMOR Foundation, Medical Institute for
Radiotherapy and Oncology of Barcelona, Spain, is one of the best places to
have cancer treatment abroad. IGRT_IMOR_2005_ENG.htm
·
Combined treatment with 3D- conformal Radiotherapy/ IGRT IMRT + Brachytherapy
either with I-125 permanent implant or HDR temporal implant, is associated
with excellent 3- and 5- year
disease-free survival rates in patients with clinically localized prostate cancer and high PSA
levels. Data has been presented by Dr Benjamin
Guix at the ASTRO (American Society for
Radiotherapy and Oncology) meeting. At the same meeting, Dr Benjamin Guix and Dra Teresa Maria Lacorte, from The IMOR Foundation, Medical Institute for
Radiotherapy and Oncology of Barcelona, Spain, presented the results obtained at IMOR Foundation with combined
treatment, with a 8-year cure rate >95% and with wxcellent
Quality of life. These studies confirm Combined
treatment as the best treatment for prostate cancer. The IMOR Foundation, Medical Institute for Radiotherapy and Oncology of
Barcelona, Spain, offers the best
option to have cancer treatment
abroad, with the highest quality.PROSTATe_COMBINED_TREAT_2005.htm
·
Dr Benjamin Guix, Director of the IMOR Foundation, Medical Institute for
Radiotherapy and Oncology of Barcelona, Spain, has presented in the World Brachytherapy Congress the long-term results of prostate brachytherapy for low- intermediate- and high-risk prostate
cancer. Results are really spectacular, with extremely high disease-free
survival and excellent quality of life. This is the best treatment for prostate cancer.
·
Dr Benjamin Guix, Director of the IMOR Foundation presents the European
experience in prostate brachytherapy during the World
Congress of Brachytherapy, the best meeting of
radiotherapy and brachytherapy.
·
Gynaecological Brachytherapy considered as the standard treatment for the best
treatment for gynaecologycal cancer, informed Dr
Jose Antonio Lejarcegui and Professor Dr Benjamin Guix, Director of The IMOR
Foundation, Medical Institute for Radiotherapy and Oncology of Barcelona, Spain. IMOR
Foundation, Medical Institute for Radiotherapy and Oncology of Barcelona,
Spain, has the best team with the highest
technology to have cancer treatment
abroad GINE1-ct.htm
·
Prostate Brachytherapy, increases local control at the same time
that decreases side-effects in prostate cancer, as shown by a multi-center study, in which the contribution of Doctors from The IMOR Foundation, Medical Institute for
Radiotherapy and Oncology from Barcelona, Sapin,
has been very important, that has been presented by Professor Dr Benjamin Guix,
Director of the IMOR Foundation at the ASCO
2005 ANNUAL MEETING (American Society for Clinical Oncology), held at
Chicago (USA). This treatment offers the best
disease-free survival and the best quality of life for prostate cancer.
·
Brachytherapy-only, is a highly effective treatment for breast recurrences.
This data have been confirmed by a trial conducted by scientifics
from The IMOR Foundation, Medical
Institute for Radiotherapy and Oncology from Barcelona, Spain, presented by
Professor Dr Benjamin Guix, at the GEC-ESTRO European Meeting on Brachytherapy, held at Lubeck
(Germany), considered the best brachytherapy meeting.
Brachytherapy is the
most effective treatment for cancer.
·
Brachytherapy offers more than 90 % local control in cancer. Professor Alain
Gerbaulet, former Head of the Brachytherapy
Unit from Institute Gustav-Roussy, made this
assertion in the
II International Oncological Meeting, invited by
Professor Dr Benjamin Guix Director of the IMOR
Foundation. Nowadays, brachytherapy offers the best results for cancer treatment. The IMOR
Foundation, Medical Institute for Radiotherapy and Oncology of Barcelona,
Spain, offers the highest technology and the
most experienced team for treating
cancer abroad in southern Europe.
·
The last 8th of april, IMOR
Foundation, Medical Insitute for Radiotherapy and
Oncology, held the Ist International Conference about Advances on
Brachytherapy. World leaders in this effective
and useful form of cancer treatment discussed about the recent developments and
discoveries and the state of the art of this extraordinary technique. The
Conference was presided by the catalan
minister of Health and Social Security Mr. Xavier Pomés.
By the IMOR Foundation, Medical Institute for Radiotherapy and Oncology of
Barcelona, Spain, presented their results Drs Antonio Arellano, Ferran Guedea and Professor Dr
Benjamin Guix and the physicist Jose Ignacio Tello, about the best
radiotherapy treatment.
·
Brachytherapy boost useful in early breast cancer. Stage I and II
breast tumors that are treated by a brachytherapy boost are doing better than those patients
without boost even if they have poor prognostic factors as positive margins,
extensive intraductal component or vascular invasion,
according to a consensus meeting held in Barcelona. Results confirm the IMOR
Foundation long-term experience, presented by Professor Dr Benjamin Guix and Jose Antonio Lejarcegui.
The results confirm the boost as the
best option of treatment for breast cancer. This data confirms The IMOR
Foundation, Medical Institute for Radiotherapy and Oncology of Barcelona, Spain,long-term experience for breast cancer treatment abroad. Brachytherapy boost in early breast cancer.
·
Local relapses
after conservative treatment for breast cancer, can be safely managed without
mastectomy by means of brachytherapy-only, as a phase II
study presented by Professor Dr Benjamin Guix Director of the IMOR
Foundation, Medical Institute for Radiotherapy and Oncology of Barcelona,
Spain, at the ASCO meeting has demonstrated. The brachytherapy is the best treatment for breast cancer
recurrences. Trat_recidivas_mama_CAST.htm
·
Temporary PSA bounces has no significant prognostic importance, as confirmed by
a paper published in the International Journal of Radiation Oncology Biology
and Physics, Dr Benjamin Guix Melcior
explained recently. The study confirms brachytherapy, alone
or in combination with IGRT-IMRT in selected cases, as the best treatment for prostate cancer. The IMOR Foundation,
Medical Institute for Radiotherapy and Oncology of Barcelona, Spain, has the longest
and highest experience in prostate
cancer treatment in souther Europe, with more
than 1,000 cases treated, and is the
best option for cancer treatment abroad. PSA SPIKES_ANG.htm
·
Partial Breast
Irradiation (PBI) by Brachytherapy-only very
effective treatment for early stage breast cancer. Differents
reports appeared in the Journal of Clinical Oncology confirm that PBI is a very
effective treatment for selected
cases of low-risk small-size breast cancer, professor Dr Benjamin Guix, Director of the IMOR Foundation, Medical Institute for
Radiotherapy and Oncology from Barcelona, Spain,, reported recently. The IMOR
Foundation, Medical Institute for Radiotherapy and Oncology of Barcelona,
Spain, has the world series with longer follow-up of
partial breast irradiation, with the
state of the art technology and best team. The IMOR Foundation, Medical Institute for Radiotherapy and Oncology of
Barcelona, Spain, is the best option to have breast cancer treatment abroad. BREAST_BRACHYTHERAPY_ONLY.htm
·
Contents about Professor
Dr Benjamin Guix Melcior,
in the best selection, Director of The IMOR Foundation,
Medical Institute for Radiotherapy and Oncology of Barcelona, Spain,
·
:
La braquiterapia como tratamiento exclusivo en pacientes con
cáncer de mama de bajo riesgo
La Braquiterapia como único
tratamiento tras cirugía conservadora en los casos precoces de
cáncer de mama, está demostrando ser tan efectiva como la
radioterapia de toda la mama. Un reciente trabajo aparecido en la revista
Internacional Journal of Radiation Oncology Biology Physics (IJROBP 2003
55:289-293), publicado por el conjunto de investigadores de Estados Unidos que
trabajan desde hace años en la irradiación parcial de la mama,
refiere que la braquiterapia exclusiva tras tumorectomía es un tratamiento seguro, con pocos
efectos secundarios y pocas complicaciones y que ofrece unos resultados (al
menos a corto plazo) similares a los obtenidos con radioterapia a toda la mama.
Las principales ventajas de la técnica están relacionadas
fundamentalmente con el acortamiento de la duración total del
tratamiento, que sería de 5 días en vez de las 5 semanas y media
que normalmente dura. En un primer momento, el tratamiento está limitado
a las pacientes con tumores de riesgo bajo, esto es tumores de hasta 2 cm de diámetro, sin ganglios axilares
positivos, menopáusicas y cuyos tumores
presenten receptores hormonales positivos.
En el mismo acto de la intervención en la cual se extirpa
el tumor mamario, se coloca en el interior de la cavidad el aplicador
de braquiterapia. Al cabo de 3 días se realiza
un TAC para la dosimetría y se inicia el tratamiento, que tiene una
duración de 5 días y se realiza de forma totalmente ambulatoria.
Una vez acabado el tratamiento se retira el aplicador
sin necesidad de anestesia, iniciándose los controles periódicos
habituales.
Los efectos secundarios que se observan en algunos casos se
reducen a un enrojecimiento de la piel situada sobre la cavidad tratada.
La Fundación IMOR, es el centro pionero en España y
Europa en estos tipos de tratamiento. Iniciados en 1990, hasta la fecha han sido
tratadas más de 100 pacientes, siendo los resultados obtenidos muy
favorables y sin complicaciones tardías relevantes. Los resultados han
sido presentados por el Profesor Benjamín Guix,
Director de la Fundación IMOR, Instituto Médico de Onco-Radioterapia, en mútiples
foros internacionales, especialmente el Congreso de ASTRO (Sociedad Americana
de Radioterapia) y de ASCO (Sociedad Americana de Oncología
Clínica). El Dr Benjamin
Guix, ha destacado en todos dichos foros la ausencia
de complicaciones a largo plazo y el hecho de que 14 de cada 15 pacientes
siguen conservado su mama en perfectas condiciones más de 15 años
después de la recaida. El Dr
Benjamin Guix, explica que
la base de estos buenos resultados radica en una cuidadosa selección de
las pacientes tributarias del tratamiento y en una depurada técnica.
“Es realmente maravilloso”, declaró Benjamin
Guix “el hecho de que sigas viendo a las
pacientes 15 años después del tratamiento en perfectas
condiciones y preservando su mama. Esto anima mucho a las pacientes y,
evidentemente a los médicos”, concluyó el prof. Benjamin Guix.
Links de interés sobre el Dr. Benjamin
Guix:
Pagina web de Fundación IMOR: www.imor.org
CV abreviado del Dr Benjamin
Guix: www.sanestconsultores.com/uploads/Dr_Benjam_n_Guix_Cv.doc
Presentacion del Dr Benjamin Guix
en la 13th Puerto Rico Breasr cancer
conference: www.acro.org/pdf/BCConference13-bro-w3.pdf
Página de noticias a cargo del Dr. Benjamin
Guix www.imor.org/noticias/contenidos3_cast
Presentacion del Dr Benjamin Guix
en la conferencia anual de ASCO www.asco.org/ASCO/Abstarcts+&+virtual+Meeting/Speaker?&spk=Guix%2C+Benjamin+%
Reseña de la presentacion de la braquiterapia transperineal para
el tratamiento del cancer de próstata
efectuada por el Dr Benjamin
Guix, aparecida en Diario Medico: http://212.80.128.9/oncologia/n140900bis.html
Otras presentaciones a cargo del Dr. Benjamin
Guix
http://profesional.medicinatv.com/webcast/muestra.asp?idfg=0&idwc=1387
http://www.sanestconsultores.com/uploads/Dr_Benjam_n_Guix_CV.doc
·